Alhomidi Almotiri is an expert in Hematology at Shaqra University (Saudi Arabia). Alhomidi Almotiri has authored 27 publications, the most recent in 2026. SLR score: 92 (community average: 125). How the SLR is computed.

LeadR Profile

Alhomidi Almotiri Shaqra University Saudi Arabia
92 ScienceLeadR Reputation 92
Network Map

Hematology

Subspecialties: Biochemistry - Genetics - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026

Source: PubMed

Shaqra University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 27

Citations

Citations: 265 1st author: 5 Last author: 0 Unique author: 4


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Metabolism of Young and Aged Hematopoietic and Acute Myeloid Leukemia Stem Cells: Insights for Rejuvenation and Therapy.
PMID 42372232 — cells, microscopy, electron, scanning transmission, aging, leukemia, stem cells, leukemia, myeloid, acute, aged, leukemia, myeloid, therapeutics, rejuvenation
Aging Dis20260
Clinical Significance of IKBKB Mutations: A Focus on IKBKB-Related Immunodeficiency.
PMID 42238289 — mutation
Saudi Med J20260
Impaired DNA damage responses and inflammatory signaling underpin hematopoietic stem cell defects in Gata2 haploinsufficiency.
PMID 40749668 — cells, microscopy, electron, scanning transmission, gata2 deficiency, leukemia, stem cells, haploinsufficiency, dna, hematopoietic stem cells, mutation, dna damage, transplantation
Stem Cell Reports20250
Treating genetic blood disorders in the era of CRISPR-mediated genome editing.
PMID 39827371 — clustered regularly interspaced short palindromic repeats, blood, anemia, sickle cell, genome, gene editing, thalassemia, hemophilia a, genetic therapy
Mol Ther20251
Identification of UBA7 expression downregulation in myelodysplastic neoplasm with SF3B1 mutations.
PMID 40158006 — cells, genes, neoplasms, alternative splicing, natural science disciplines, therapeutics, down-regulation, mutation, gene expression
Sci Rep20250

LeadR Networks

Main global connection map